ReviewNeurology and therapy2024

Twenty Years of Subcutaneous Interferon-Beta-1a for Multiple Sclerosis: Contemporary Perspectives.

Mark S Freedman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.